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We have previously shown that changes in estrogen-
hepatocyte interaction occur during liver regeneration. 
Following 70% hepatectomy, estrogen levels in the blood 
were elevated, the number of estrogen receptors in the 
liver was increased and there was an active transloca-
tion of estrogen receptors from the cytosol to the nu-
cleus. The injection of tamoxifen, an estrogen antago-
nist, inhibits hepatocyte proliferation following partial 
hepatectomy. The administration of 1 fJ.g tamoxifen per 
gm body weight at zero time or 6 hr after the operation 
resulted in a significant inhibition both of DNA synthe-
sis and of the number of cells in mitosis. Injections of 
tamoxifen 12 hr or later after the operation had no 
effect. Concomitant injections of equimolar amounts of 
estrogen abolished the inhibition by tamoxifen. The ef-
fects of estrogen and tamoxifen were also tested on 
hepatocytes in primary culture. Estrogens in the pres-
ence of 5% normal rat serum stimulated hepatocyte DNA 
synthesis as determined by [3H]thymidine incorporation 
and the labeling index, whereas epidermal growth fac-
tor-induced DNA synthesis in the absence of normal rat 
serum was strongly inhibited. Tamoxifen, in contrast, 
inhibited DNA synthesis of hepatocytes in the presence 
of 5% normal rat serum and reversed the stimulatory 
effect of estrogen in the same system. Attempts to elu-
cidate the mechanism of tamoxifen inhibition in vitro 
indicated that one effect of tamoxifen is to prevent the 
amiloride-sensitive Na+ influx necessary to initiate he-
patocyte proliferation. 
There is now considerable experimental evidence that 
sex hormones may modulate the process of liver regen-
eration. We have demonstrated an increase in estrogen 
receptors in the rat liver after 70% partial hepatectomy 
(1,2). We have extended these results to demonstrate a 
complete interdependence of sex hormones and their 
receptors in the liver during the regenerative process (3). 
Testosterone levels in the serum decrease precipitously 
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following 70% hepatectomy, whereas concomitant serum 
estrogen levels become significantly elevated. Partial 
hepatectomy induces significant alterations in the abso-
lute number of hepatic sex hormone receptors. There 
was a significant and rapid reduction of cytosolic and 
nuclear androgen receptors, whereas estrogen receptors 
increased rapidly in the nuclear fraction (3). The degree 
of alteration in estrogenic physiology after hepatectomy 
is further emphasized by the reduction of the cytosolic 
male estrogen-binding protein and the microsomal en-
zyme estrogen 2-hydroxylase, which represent two sys-
tems responsive to androgenic modulation. Despite these 
consistent changes, the exact role of estrogens and sig-
nificance in the overall process of liver regeneration 
remain to be elucidated. The experiments reported here 
were designed to define further the role of estrogenic 
hormones and their receptors in liver regeneration by 
assessing the effect oftamoxifen, an estrogen antagonist, 
in both in vivo and in vitro models. 
MATERIALS AND METHODS 
Animals. Male Fischer F344 rats weighing between 180 
and 200 gm were obtained from Hilltop Lab Animals, Inc. 
(Scottdale, PA). The animals were housed in a temperature-
and light- (6 a.m. to 6 p.m.) controlled room and received food 
and water ad libitum. Seventy per cent partial hepatectomy 
(PH) was performed as previously described by Higgins and 
Anderson (4). Sham hepatectomy consisted of laparotomy and 
gentle manipulation of the liver. All surgical procedures were 
performed between 8:00 and 10:00 a.m. All injections were 
administered by the intraperitoneal route. 
Materials. Collagenase (Type I) (140 to 170 units per mg) 
was purchased from Worthington Diagnostic Systems (Free-
hold, NJ). Eagle's MEM and fetal calf serum (FCS) were 
purchased from GIBCO Laboratories (Grand Island, NY). In-
sulin, HEPES, pyruvic acid, tamoxifen and estrogen (17fJ-
estradiol) were purchased from Sigma Chemical Co. (St. Louis, 
MO). Epidermal growth factor (EGF) was purchased from 
Collaborative Research, Inc. (Bedford, MA). [methyPH]Thy-
midine (50 to 80 Ci per mmole), [22Na+]sodium chloride in 
water (532 mCi per mg) and 125I_EGF (150 to 200 fJ.Ci per ~gF 
were purchased from New England Nuclear (Boston, MA). 
Gentamicin was purchased from Elkins-Sinn, Inc. (Cherry Hill, 
NJ). Aqueous counting solution was purchased from Amersham 
(Arlington Heights, IL). 
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Drug Administration. Both tamoxifen and estradiol 
were dissolved in 100% ethanol at a concentration of 10 mg per 
ml. For in vivo experiments, a solution of 1:25 (v/v) in saline 
was prepared from the above concentration immediately before 
the i.p. injection. Control animals received an injection of a 
saline solution containing 4% ethanol. 
For in vitro experiments, 10 mg estradiol or tamoxifen were 
dissolved in 1 ml ethanol and were diluted in culture medium 
(0.4 to 1:1,000 v/v). It was essential to keep the amount of 
ethanol as small as possible, as even 0.5% of ethanol was quite 
toxic for the cells. In all experiments in which tamoxifen or 
estrogen was added, control culture received the same amount 
of ethanol used for the addition of tamoxifen and estrogen. [3H] 
Thymidine incorporation was the same in the absence or pres-
ence of these levels of ethanol. 
This study has been approved by the Research and Devel-
opment Committee of our institution. 
In Vivo fHjThymidine Incorporation. To measure 
hepatic DNA synthesis, rats were given intravenous injections 
of 50 jlCi ["H]thymidine per 200 gm body weight 1 hr prior to 
killing; 1 hr later, the animals were killed and the incorporation 
of [3H]thymidine and the percentage of labeled nuclei were 
determined as previously described (5, 6). 
Binding Studies. Purified plasma membrane fractions 
were prepared by the method of Neville (7) from normal rats 
and hepatectomized rats treated with or without tamoxifen. 
The purity of the membrane preparation was assessed by the 
assay of 5' -nucleotidase activity. Radiolabeled ligands were 
incubated with 9 to 25 jlg membrane protein for 40 min at 24°C 
in 0.2 ml Dulbecco's phosphate-buffered saline containing 0.1 % 
bovine serum albumin. Duplicate samples were collected on 
Millipore EGWP filters (Millipore Corp., Bedford, MA). Each 
determination was corrected for nonspecific binding by sub-
traction of 125I_EGF bound in the presence of 1 /lM native EGF 
added 10 min prior to the labeled material (8). The Bmax and 
Kd were calculated by Scatchard analysis (9). 
Hepatocytes in Primary Culture. Hepatocytes were 
isolated from 7-week-old male rats weighing between 180 and 
200 gm, by a modification of the in situ two-step collagenase 
perfusion technique of Seglen (10) and Jirtle et al. (ll) and 
modified further, as previously described (12). The hepatocytes 
were dispersed and washed twice with cold Ca++ -free perfusion 
buffer and resuspended in basal medium (MEM) supplemented 
with pyruvate (1 mM), aspartate (0.2 mM), serine (0.2 mM), 
gentamicin (40 mM), proline (0.26 mM), insulin (10-7 M) and 
5% FCS. Viability was determined by trypan blue exclusion 
(12), and only preparations having greater than 90% viability 
were used. Cell number was determined with a hemocytometer. 
The cells were plated at a cell density of 6.5 x 104 per well 
in Falcon "Primaria" 24-well tissue culture plates in 0.5 ml 
medium and maintained at 37°C in a 5% CO2 atmosphere. The 
surface area of each wel[.was 2 cm2. Following a 3-hr attachment 
period, the medium was aspirated, 0.5 ml serum-free basal 
medium was added and hormonal additions were made as 
indicated. EGF and insulin were at a concentration of 10 ng 
per ml and 10-7 M, respectively. In the experiments with ta-
moxifen, the culture medium was always supplemented with 
5% normal male rat serum (NRS). This concentration of serum 
was necessary to protect hepatocytes from the cytotoxic effects 
of tamoxifen observed in serum-free medium. 
In Vitro fH1Thymidine Incorporation. To determine 
in vitro DNA synthesis, 3 jlCi [3H]thymidine were added to 
each well and maintained from 24 to 48 hr or from 48 to 72 hr 
of the culture period. Each experimental group consisted of six 
wells. When the cells were harvested, three wells were used to 
determine DNA content by the microfluorometric method of 
Setaro and Morley (13), and the three remaining wells of each 
group were treated as described by Michalopoulos et al. (14) to 
measure the DNA synthesis (incorporation of [3HJthymidine). 
Autoradiography. For autoradiographic studies, hepa-
tocytes were plated in 35-mm dishes as previously described 
(12, 15). [3HJThymidine, 7.5 /lCi per dish, was present for 24 
hr prior to fixation. Fixed cells in the dishes were covered with 
emulsion (Kodak NTB3), and the dishes were developed after 
10 days. The labeling index was determined by counting a total 
of 1,000 cells per dish. 
Measurement of 22Na+ Uptake. Uptake of 22Na+ was 
determined essentially as described by Koch and Leffert (16) 
using hepatocytes cultured in 35-mm Primaria culture dishes. 
Following a 3-hr attachment period, the medium was removed 
and 1.5 ml per well of serum-free basal MEM were added. The 
plates were left at 37°C in a 5% CO2 atmosphere for 20 hr. The 
plates were then washed twice with serum-free MEM contain-
ing 0.4 mM ouabain, and/or 0.4 mM amiloride where indicated. 
The basic incubation medium was MEM plus 10-7 M insulin, 
0.4 mM ouabain and 2 /lCi per ml 22Na+. Where indicated, 
estrogen and 5% NRS were added as the mitogens and tamox-
ifen as potential inhibitor. Duplicate dishes were set up in each 
experiment in the presence of 0.4 mM amiloride. Incubation 
was for 90 min at 37°C in a 5% CO2 atmosphere. Following the 
90-min incubation, the cultures were washed with 1 ml of cold 
250 mM sucrose, pH 6.0, and the radioactivity was extracted 
by the addition of 1 ml of 330 mM NaOH at 37'C for 30 min. 
The supernatant was transferred to scintillation vials contain-
ing 0.1 ml 40% trichloroacetic acid and 10 ml aqueous scintil-
lation solution, and radioactivity was determined in a Packard 
scintillation counter. 
Other Methods. Proteins were determined by the method 
of Lowry et al. (17). The unpaired Student's t test was used for 
statistical analysis of the data. 
RESULTS 
Tamoxifen administration resulted in an inhibition 
(77%) of the peak incorporation of [3H]thymidine and of 
DNA synthesis normally observed in rats at 20 to 24 hr 
following PH (Table 1). DNA synthesis in the livers of 
sham-operated rats was not affected by tamoxifen. This 
latter result was to be expected, since the DNA synthesis 
in the livers of normal or sham-operated rats is very low; 
thus, an inhibition would not be obvious. 
Administration of tamoxifen immediately after PH 
was not critical for the inhibition of DNA synthesis. As 
TABLE 1. Effect of tamoxifen on liver regeneration 
[8HjThymidine 
Treatment No. of rats incorporation 
(cpm/I'g DNA) 
Sham hepatectomy 7 7,500 ± 1,260 
Sham hepatectomy + 6 6,950 ± 1,320 
tamoxifen 
70% hepatectomy 10 82,270 ± 25,820 
(control) 
70% hepatectomy + 10 19,195 ± 12,650a 
tamoxifen 
A 70% hepatectomy or a sham hepatectomy was performed on male 
rats between 8 and 10 a.m. One microgram of tamoxifen per gm body 
weight of rat was injected i.p. immediately after the operation. Rats 
were given i.p. infections of 50 !LCi [3H]thymidine at 23 hr after the 
operations and killed 1 hr later. The numbers are the averages ± S.D. 
a Significantly different from the 70% hepatectomy control value 
(p < 0.01). 
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can be seen in Figure 1, injection of tamoxifen at 6 hr 
after PH still resulted in a significant inhibition of PH) 
thymidine incorporation. Tamoxifen administration at 
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FIG. 1. Administration of tamoxifen at different times after 70% 
partial hepatectomy. All operations were performed at time 0, between 
8 and 10 a.m. Injections of 1 )Lg per gm body weight tamoxifen were 
administered at indicated times after operation. All animals were given 
injections of 50 )LCi [3Hlthymidine at 23 hr after the operation. One 
hour later, animals were killed, and hepatic DNA synthesis and labeled 
nuclei were determined. The values represented by the bar are means 
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FIG. 2. Reversal of tamoxifen inhibition of DNA synthesis by estro-
gen. All animals had 70% of the liver removed between 8 and 10 a.m. 
Where indicated, tamoxifen (1 )Lg per gm body weight) and/or estradiol 
(0.8)Lg per gm body weight) were injected at zero time after the surgical 
procedure. DNA synthesis at 24 hr was determined as indicated for 
Fig. 1. The values represented by the bars are the means from at least 
five rats ± S.D. * = significantly different from control value, p < 0.01. 
no longer inhibitory. Also shown in Figure 1 are autora-
diographic data confirming the [3H)thimidine incorpo-
ration results. These findings suggest that an early event 
in the hepatic regenerative process may be sensitive to 
tamoxifen. 
The inhibitory effect of tamoxifen could be reversed 
by the simultaneous administration of an equimolar 
amount of estradiol as shown in Figure 2. In the presence 
of tamoxifen, hepatic DNA synthesis was only 23% of 
that of the control rats which had not received any drug 
injections. The simultaneous injection of estradiol with 
tamoxifen reversed the inhibitory effect of tamoxifen 
and restored normal DNA synthesis as induced by partial 
hepatectomy. 
Our finding that estradiol prevents the tamoxifen in-
hibition of DNA synthesis is further supported by the 
results shown in Figure 3. In male rats, the inhibition of 
DNA synthesis by tamoxifen lasts until 32 hr after 
partial hepatectomy, whereas in female rats inhibition is 
apparent only at 24 hr after the operation. Thus, the 




























24 28 32 36 40 
Hours After Partial Hepatectomy 
FIG. 3. Duration of tamoxifen inhibition of hepatocyte proliferation 
activity in vivo expressed as labeled nuclei following partial hepatec-
tomy in male and female rats. All operations were performed between 
8 and 10 a.m. Tamoxifen (1 )Lg per gm body weight) was injected at 
zero time after the operation. All animals were given injections of 50 
)LCi [3Hlthymidine 1 hr before they were killed. At specified times after 
partial hepatectomy, indicated on the abscissa, the animals were killed 
and labeled nuclei were determined as described (6). The values rep-
resented by each bar were derived from four controls and four tamoxi-
fen-injected rats. Open bars = controls; hatched bars = tamoxifen-
injected animals. 
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also indicate that tamoxifen does not kill the hepato-
cytes. Liver weight was almost fully restored at 10 days 
after partial hepatectomy, whether tamoxifen had been 
injected at the time of the operation or not. 
As demonstrated in Table 2, tamoxifen also inhibited 
DNA synthesis drastically and in a dose-dependent fash-
ion when added to hepatocyte cultures in the presence 
of 5% NRS. The results in Figure 4 demonstrate that 
the addition of tamoxifen as late as 36 hr after plating 
caused a 40% inhibition. Tamoxifen did not appear to be 
cytotoxic in our experimental conditions as evaluated by 
the trypan blue exclusion test and DNA amount per dish 
(data not shown). 
Table 3 reports the effect of estrogens on hepatocyte 
TABLE 2. Inhibition of DNA synthesis in hepatocytes in 
primary culture in the presence of 5% normal rat serum 
Amount of [3HlThymidine 
tamoxifen added incorporation % labeled nuclei 
(I'M) (cpm/I'g DNA) 
0 54,730 ± 5,460 8±2 
2.5 43,218 ± 3,910 6 ± 1.5 
5 21,007 ± 3,008a 4 ± 0.2" 
10 13,338 ± 874" 2.5 ± 0.25" 
The preparation of hepatocyte cultures and the assay conditions are 
described in "Materials and Methods." The numbers are means of at 
least four different determinations ± S.D. Wells are exposed to 3 /LCi 
[3H]thymidine from 24 to 48 hr in culture. 
" Significantly different from the value obtained using no tamoxifen 
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* p < 0.01 
**p<0.05 
FIG. 4. Effect of tamoxifen added to hepatocytes at various times 
after plating. Hepatocytes were isolated and plated as described in 
"Materials and Methods." After 3 hr, the attachment medium was 
replaced with NRS-containing basal medium. At indicated times, three 
wells for each point received tamoxifen (4 mM). All wells received 3 
I'Ci [3H]thymidine at 24 hr. The cells were harvested at 48 hr. The 
values shown are the averages of at least three determinations with 
individual values within 5% of the mean shown. Significantly different 
from control value: • = p < 0.01; ** = < 0.05. 
TABLE 3. Effect of estrogen on hepatic proliferation in the 





added (I'M) --+-E-G-F----+-5-% NRS 
% labeled nuclei 
+EGF + 5% NRS 
None 67,245 ± 5,350 60,321 ± 7,750 10 ± 4 9 ± 3 
2.5 51,119 ± 6,350 90,175 ± 7,350 9.1 ± 2.7 11 ± 2 
5 36,471 ± 1,850" 119,803 ± 11,320" 6.8 ± 2 14 ± 3 
10 20,984 ± 1,820" 132,616 ± 9,180" 3.1 ± 1" 16 ± 2" 
The assay conditions were as for Table 2. After a 3-hr attachment 
period, the medium was removed and replaced with MEM plus insulin 
containing either EGF (10 ng per ml) or 5% NRS. The values are the 
means from three determinations ± S.D. 
a Significantly different from the control value (none) (p < 0.005). 
TABLE 4. Effect of tamoxifen on estrogen-stimulated DNA 
synthesis in hepatocytes in primary culture in the presence of 
normal rat serum 
Amount [3HlThymidine Additions (I'M) incorporation (cpm/I'g DNA) 
None 41,000 ± 4,100 
17 {3-Estradiol 2.5 48,000 ± 3,250 
17 {3-Estradiol 5 58,120 ± 3,120 
17 {3-Estradiol 10 72,100 ± 8,200 
Tx" 5 13,000 ± 950 
Tx (10 I'M) + 17{3-estradiol 2.5 5,600 ± 1,510 
Tx (10 I'M) + 17{3-estradiol 5 9,100 ± 910 
Tx (10 I'M) + 17{3-estradiol 10 13,120 ± 1,350 
Assay conditions were as for Table 2. After a three-hr attachment 
period, the medium was removed and replaced with MEM + insulin 
containing 5% normal rat serum. The values are the means of three 
determinations ± S.D. 
a TX = tamoxifen. 
proliferation in the presence of 5% NRS or in the pres-
ence of EGF in serum-free medium. At the concentra-
tions shown, estrogen inhibited EGF-induced DNA syn-
thesis, as previously demonstrated (18). In contrast, in-
creased DNA synthesis and an increase in the labeling 
index was observed when estrogen was administered in 
the presence of 5% NRS. This increase in DNA synthesis 
due to estrogen can be inhibited by tamoxifen, as shown 
in Table 4. DNA synthesis stimulated by estrogens in 
the presence of 5% NRS was completely inhibited by 4 
f.LM tamoxifen . 
To understand the possible mechanism of tamoxifen 
effect, we investigated whether this drug would alter EGF 
receptor affinity or distribution. We compared EGF 
binding on isolated plasma membranes of normal rat 
liver with that of regenerating rat liver, injected with 
saline or tamoxifen. Our results indicated that tamoxifen 
had no effect on the down-regulation of EGF receptors 
following partial hepatectomy (8, 18). For normal rats, 
we found EGF binding values of Bm • x = 1.2 ± 0.3 pmoles 
per mg protein and Kd = 1.08 ± 0.12 nM. For regener-
ating rat liver, we found Bmax = 0.56 ± 0.12 pmole per 
mg protein and Kd = 1.32 ± 0.13 nM, not significantly 
different from those observed in hepatectomized rats 
treated with tamoxifen (Bmax = 0.48 ± 0.15 pmoles per 
mg; Kd = 1.28 ± 0.13 nM). 
------------------- ------------------ ---------------
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TABLE 5. Inhibition of 22N a+ uptake by tamoxifen in 




MEM + estrogen (10 p,M) 
MEM + estrogen (10 p,M) + 5% 
NRS 
MEM + 5% NRS + Tx (10 p,M) 
MEM + estrogen (10 p,M) + 5% 
NRS + Tx (10 p,M) 
22Na+ uptake (cpm/5 x 105 
cells) 
(-) Amiloride 
2,542 ± 250 
2,866 ± 186 
3,072 ± 180 
3,820 ± 150 
1,212 ± 96" 
1,025 ± 83" 
(+) Amiloride 
(0.4mM) 
2,858 ± 420 
2,010 ± 120 
2,675 ± 190 
2,820 ± 205 
1,157 ± 120" 
950 ± 141b 
The isolation and culture conditions of hepatocytes and the deter-
mination of 22Na+ uptake have been described in "Materials and 
Methods." Following the 3-hr attachment period, the medium was 
removed and the cells were incubated in MEM for 20 hr. The indicated 
additions were then made, including 2 p,Ci 22Na+ per dish, 0.4 mM 
ouabain and insulin, and the cells were incubated for 90 min. The 
numbers are the means from six dishes ± S.D. Tx = tamoxifen. 
"Significantly different from the value obtained using MEM + 5% 
NRS (p < 0.05). 
b Significantly different from the value obtained using MEM + 
estrogen (10 p,M) + 5% NRS. 
The experiment reported in Table 5 shows the effect 
of tamoxifen on amiloride-sensitive Na+ flux, which is 
known to be one of the earliest phenomena occurring in 
hepatocyte proliferation (16). It has been well established 
that there is an increase Na+ flux into hepatocytes due 
to the presence of mitogens in culture media and that 
this increase can be abolished by 0.4 mM amiloride. Our 
results indicate that Na+ amiloride-sensitive flux, evi-
dent in the presence of the mitogens 5 % NRS or estrogen 
(10 IlM), is inhibited by tamoxifen. 
DISCUSSION 
Since Higgins and Anderson (4) originally reported the 
technique of partial hepatectomy in rats, investigators 
have been studying the mechanisms that regulate hepatic 
regeneration. During the last 10 years, hormones have 
assumed a prominent role as factors related in some way 
to hepatic regeneration after partial hepatectomy. It has 
been suggested that hormonal agents such as insulin, 
glucagon and epidermal growth factor may initiate the 
process ofregeneration (19-28); however, hormones such 
as parathyroid hormone (27), calcitonin (23), iodothy-
ronines (28) and glucocorticoids (29) also have been 
shown to influence the hepatic regenerative response. 
In a recent series of studies, our group reported several 
important relationships between steroid receptors and 
liver function (30-32), and particularly the changes in 
sex hormones and their receptors during liver regenera-
tion (1-3). First, we described changes in cytosolic and 
nuclear estrogen receptors in regenerating male rat liver 
during the first 72 hr after 70% partial hepatectomy (1). 
These data demonstrated that a significant increase in 
the number and nuclear localization of hepatic estrogen 
receptors was concurrent with the proliferative activity 
of the regenerating liver. 
More recently, significant variations in serum andro-
gen levels and changes in the hepatic distribution of the 
specific cytosolic and nuclear androgen receptors have 
been reported during liver regeneration in male rats (3). 
Concomitantly, testosterone levels decreased precipi-
tously following 70% hepatectomy. As a further demon-
stration of the process of feminization in regenerating 
rat liver, we have also described a reduction in the 
cytosolic male estrogen-binding protein and of the mi-
crosomal enzyme, estrogen 2-hydroxylase, two systems 
responsive to androgenic modulation. 
Our most recent results also determined that estrogen 
decreased the number of EGF receptors of male hepato-
cytes in culture. We have shown that this effect accounts 
for the inability of EGF to stimulate hepatocyte prolif-
eration in vitro in the presence of estrogen and also helps 
explain the difference in liver EGF receptors, found by 
us and others, between male and female hepatocytes 
(18). The experiments in vivo and in vitro reported in 
this paper clearly show that tamoxifen, an antiestrogenic 
agent, strongly inhibits hepatocyte proliferation. This 
inhibition is maximal when tamoxifen is injected in vivo 
immediately after the hepatectomy and in vitro when the 
drug is added to the cultures during the first 30 hr. 
Our data raised three major questions which are re-
lated to the role that estrogen plays in hepatocyte prolif-
eration: (i) Does tamoxifen affect EGF receptors in the 
liver? (ii) Is the inhibitory effect of tamoxifen mediated 
by the binding to the estrogen receptor? (iii) What is the 
mechanism of action of estrogen and tamoxifen on hep-
atocyte proliferation? 
In regard to the first question, our data show that 
tamoxifen does not change the behavior of EGF receptors 
during regeneration; in fact, Bmax and Kd were similar in 
rat livers 24 hr after hepatectomy, whether or not the 
rats had been treated with tamoxifen. This demonstrates 
that the tamoxifen effect is due to an inhibition of some 
intracellular biochemical reaction which might be inde-
pendent of EGF receptor interactions. With respect to 
the second question regarding the binding of tamoxifen 
to liver estrogen receptors, it is likely that this is the 
case, since tamoxifen competes effectively for estradiol 
binding to estrogen receptor in human liver (33). The 
possibility that tamoxifen is interacting with anti-estro-
gen-binding proteins, recently demonstrated in micro-
somal fractions of the liver (34, 35), is very unlikely. 
These proteins differ from estrogen receptors by a dif-
ferent pH stability profile, a different sensitivity to pro-
tease and a typical ligand binding specificity. In addition, 
these proteins show a moderate affinity for compounds 
like tamoxifen which have antiestrogenic potencies. The 
results, in vivo and in vitro, reported in this paper 
strongly suggest that the inhibitory effect of tamoxifen 
is due to its ability to bind to estrogen receptors, since 
the inhibition in vivo is removed by the simultaneous 
administration of equimolar amounts of estradiol and in 
vitro the stimulatory effect of estrogen in the presence 
of 5 % NRS is abolished by tamoxifen. 
The third point is more difficult to answer. Our data 
show that in order to influence regeneration, tamoxifen 
has to be administered very early after hepatectomy. It 
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has recently been reported that tamoxifen is able to 
inhibit proliferation of different cell types by blocking 
the transition of the GO/G1 phase of the cell cycle (36-
40). A reversal of this effect by estrogen has also been 
shown (36). Our in vivo and in vitro results indicate that 
the inhibitory effect of tamoxifen also occurs durirtg the 
first stages of hepatocyte proliferation. The difference in 
sensitivity between in vivo (6 hr) and in vitro (36 hr) 
conditions reported by us is most likely due to a lack of 
synchrony in the hepatocyte cultures and to the difficulty 
in determining the true zero time for stimulation by 
mitogens. The results reported in Table 5 indicate that 
tamoxifen inhibits Na+ influx, which is an early event in 
hepatocyte proliferation, according to Koch and Leffert 
(16). Probably as important is our finding, also shown in 
Table 5, that estrogen increases the Na+ flux. The finding 
that Na+ influx is increased when estrogen is added to 
hepatocyte cultures provides further evidence for the 
mitogenic properties of estrogen and also suggests that 
estrogen acts early in the progression of hepatocytes from 
a quiescent to a proliferative state. Therefore, other 
mechanisms by which tamoxifen may exert its inhibitory 
effect must also be considered. Although there is no 
evidence that the activation of protein kinase C is mito-
genic for hepatocytes, it is possible that estrogen and 
tamoxifen modulate the expression of this protein (41, 
42). Tamoxifen is also known to inhibit calmodulin (43) 
and the importance of calmodulin in cell proliferation is 
well known (44). 
At present, it is difficult to reach a final conclusion on 
the complex effects of both estrogen and tamoxifen on 
hepatocyte proliferation. This report, however, provides 
additional evidence that estrogen has mitogenic proper-
ties for hepatocytes in vivo and in vitro and may play an 
important role in hepatocyte proliferation. 
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